Leuprorelin/norethisterone acetate
Combination medication
From Wikipedia, the free encyclopedia
Leuprorelin/norethisterone acetate, also known as leuprolide/norethindrone acetate and sold under the brand name Lupaneta Pack, is a co-packaged medication used to treat endometriosis.[1] It contains leuprorelin as the acetate, a gonadotropin-releasing hormone agonist, and norethisterone acetate, a progestin.[1] The leuprorelin is given by intramuscular injection and the norethisterone acetate is taken by mouth.[1]
Trade namesLupaneta Pack
Other namesLeuprolide/norethindrone acetate
| Combination of | |
|---|---|
| Leuprorelin | Gonadotropin-releasing hormone agonist |
| Norethisterone acetate | Progestin |
| Clinical data | |
| Trade names | Lupaneta Pack |
| Other names | Leuprolide/norethindrone acetate |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| License data | |
| Routes of administration | Intramuscular and by mouth |
| ATC code |
|
| Legal status | |
| Legal status | |
The co-packaged medication was approved for medical use in the United States in December 2012.[2]
